Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05285735 · ClinicalTrials.gov registry record
Observational Study of the Safety of Intravenous Artesunate Treatment of Pregnant Women and Their Infants
A clinical trial of Pregnancy and Malaria, sponsored by Amivas.
- Recruiting
- Registry status
- 25
- Enrollment target
- 1
- Study location
NCT05285735 is a study of Pregnancy and Malaria that is actively recruiting participants, run by Amivas. The registered enrollment target is 25 participants, below the 873-participant average among 191 other Pregnancy trials with a reported enrollment target (97% lower). The trial reports 1 study location across 1 state.
The verdict
NCT05285735, a study of Pregnancy and Malaria, is actively recruiting participants, sponsored by Amivas.
- RECRUITING
- Registry status
- 25 participants
- Enrollment target
- 1
- Study location
Study Summary
This study is a prospective observational study in which a female patient who received IV Artesunate while pregnant can volunteer to provide information about her pregnancy and the outcome of her pregnancy. Information will be collected from patient's provider, the patient's obstetrician, the child's pediatrician, or other relevant healthcare provider.
Study Locations (1)
New Jersey
- 4C Pharma Solutions - Piscataway
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 25 participants |
| Start Date | 2022-06-08 |
| Est. Completion | 2029-07-01 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05285735
The ClinicalTrials.gov registry entry for NCT05285735 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 25 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 873-participant average among 191 other Pregnancy trials with a reported enrollment target (97% lower). The listed sponsor is Amivas, which has 2 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with Pregnancy appearing as the primary indexed condition, and to 0 interventions.
NCT05285735 reports 1 study location spanning 1 distinct geographic area - top geographies include New Jersey.
Frequently Asked Questions
What is clinical trial NCT05285735 about?
NCT05285735 is a clinical study titled "Observational Study of the Safety of Intravenous Artesunate Treatment of Pregnant Women and Their Infants". This study is a prospective observational study in which a female patient who received IV Artesunate while pregnant can volunteer to provide information about her pregnancy and the outcome of her pregnancy. Information will be collected from patient's provider, the patient's obstetrician, the child'...
What is the current status of trial NCT05285735?
This trial is currently recruiting. The enrollment target is 25 participants. The study started on 2022-06-08. Estimated completion is 2029-07-01.
What conditions does trial NCT05285735 study?
This clinical trial studies the following conditions: Pregnancy, Malaria.
Who is sponsoring clinical trial NCT05285735?
This trial is sponsored by Amivas, which has 2 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05285735 being conducted?
This trial has 1 study location across New Jersey. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Pregnancy
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Stelara and Tremfya Pregnancy Exposure Registry OTIS Autoimmune Diseases in Pregnancy Project
RECRUITING
-
CGM Adherence Compared to Finger-stick Glucose Monitoring in Pregnancies With Type 2 Pregestational Diabetes
RECRUITING · NA
-
Healthy Start: Exploring the Fuel-mediated Programming of Neonatal Growth
RECRUITING
-
Cocooned Moms Study
RECRUITING · NA
-
Retinal Vascular Changes During Pregnancy
RECRUITING
-
CGM for Management of Type 2 Diabetes in Pregnancy
RECRUITING · NA
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.